🇺🇸 4SC-201 in United States

4 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 4

Most-reported reactions

1. Blood Potassium Decreased — 1 report (25%)
2. Conduction Disorder — 1 report (25%)
3. Electrocardiogram Qt Prolonged — 1 report (25%)
4. Troponin I Increased — 1 report (25%)

Source database →

Frequently asked questions

Is 4SC-201 approved in United States?

4SC-201 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for 4SC-201 in United States?

4SC AG is the originator. The local marketing authorisation holder may differ — check the official source linked above.